Fluoxetine market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.10% in the above mentioned forecast period.

Fluoxetine is selective serotonin reuptake inhibitor (SSRI) antidepressant which works by blocking the reuptake of SSRI by neurons. It is referred to a prescription drug which is available in various dosage forms including tablet, solution, capsule, syrup, and delayed-release capsule. It is also available as generic drug. Sarafem, prozac, selfemra and prozac weekly are the brand names for this drug. This medication is helpful in the treatment of obsessive-compulsive disorder, panic disorder, depression, bulimia nervosa and premenstrual dysphoric disorder (PMDD).

The rise in the prevalence of bulimia nervosa and obsessive-compulsive disorder will act a major driver for the expansion of fluoxetine market. Furthermore, increasing geriatric population, rising healthcare expenditure and increase in the number of patients suffering from depression are the factors that will expand the fluoxetine market. Other factors including rise in the growing government initiatives, changing lifestyle and rising awareness will positively impact the market growth rate.

Moreover, the rise in the research and development activities, new product launches and strategic collaborations will provide beneficial opportunities for the fluoxetine market in the forecast period of 2021-2028.

Access Full Report : https://www.databridgemarketresearch.com/reports/global-fluoxetine-market

Global Fluoxetine Market Scope and Market Size

The fluoxetine market is segmented on the basis of drug class, application, demographic, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of drug class, the fluoxetine market is segmented into antidepressant, selective serotonin reuptake inhibitor (SSRI).
• On the basis of application, the fluoxetine market is segmented into obsessive-compulsive disorder, panic disorder, depression, bulimia nervosa and others.
• On the basis of demographic, the fluoxetine market is segmented into adult, pediatric and geriatric.
• On the basis of dosage form, the fluoxetine market is segmented into tablet, solution, capsule, syrup, and others. Tablet segment is further sub-segmented into 10mg, 20mg, and 60mg. Capsule segment is further sub-segmented into 10mg, 20mg, and 40mg. Solution segment is further sub-segmented into 20mg/5ml and others.
• On the basis of route of administration, the fluoxetine market is segmented into oral and others.
• On the basis of end-users, the fluoxetine market is segmented into clinic, hospital and others.

Patient Epidemiology Analysis

Fluoxetine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Fluoxetine Market Share Analysis

Fluoxetine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to fluoxetine market research.

Some of the major players operating in the fluoxetine market are Teva Pharmaceutical Industries Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Mylan N.V., Dr. Reddy’s Laboratories Ltd., Eli Lilly and Company, WOCKHARDT, Alembic Pharmaceuticals Limited, Lannett, Pharmaceutical Associates Inc., Alvogen, Torrent Pharmaceuticals Ltd., Suzhou Yushi Pharmaceutical Co., Ltd., Apotex Inc., Accord Healthcare, ANGITA, and Changzhou Siyao Pharmaceuticals Co. Ltd., among others.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- [email protected]